Search Results - "Van Mieghem, N M"

Age is no factor in TAVI by Adrichem, R., Van Mieghem, N. M.

“…[...]meticulous patient selection is key to minimise futility in elderly patients with a plethora of phenotypes. [...]attention in the Netherlands should now…”
Get full text

Generalized pairwise comparison methods to analyze (non)prioritized composite endpoints by Verbeeck, J., Spitzer, E., Vries, T., Es, G.A., Anderson, W. N., Van Mieghem, N.M., Leon, M.B., Molenberghs, G., Tijssen, J.

“…In the analysis of composite endpoints in a clinical trial, time to first event analysis techniques such as the logrank test and Cox proportional hazard test…”
Get full text

Immediate versus staged revascularisation of non-culprit arteries in patients with acute coronary syndrome: a systematic review and meta-analysis by Vriesendorp, P. A., Wilschut, J. M., Diletti, R., Daemen, J., Kardys, I., Zijlstra, F., Van Mieghem, N. M., Bennett, J., Esposito, G., Sabate, M., den Dekker, W. K.

“…Although there is robust evidence that revascularisation of non-culprit vessels should be pursued in patients presenting with an acute coronary syndrome (ACS)…”
Get full text

Prognostic value of post-percutaneous coronary intervention diastolic pressure ratio by Masdjedi, K., van Zandvoort, L. J. C., Neleman, T., Kardys, I., Ligthart, J., Den Dekker, W. K., Diletti, R., Zijlstra, F., Van Mieghem, N. M., Daemen, J.

“…Aim To evaluate the distribution of a generic diastolic pressure ratio (dPR) after angiographically successful percutaneous coronary intervention (PCI) and to…”
Get full text

Endovascular renal sympathetic denervation to improve heart failure with reduced ejection fraction: the IMPROVE-HF-I study by Feyz, L., Nannan Panday, R., Henneman, M., Verzijlbergen, F., Constantinescu, A. A., van Dalen, B. M., Brugts, J. J., Caliskan, K., Geleijnse, M. L., Kardys, I., Van Mieghem, N. M., Manintveld, O., Daemen, J.

“…Introduction The aim of the present study was to assess the safety and efficacy of renal sympathetic denervation (RDN) in patients with heart failure with…”
Get full text

Transcatheter aortic valve implantation amid the COVID-19 pandemic: a nationwide analysis of the first COVID-19 wave in the Netherlands by Rooijakkers, M. J. P., Li, W. W. L., Stens, N. A., Vis, M. M., Tonino, P. A. L., Timmers, L., Van Mieghem, N. M., den Heijer, P., Kats, S., Stella, P. R., Roolvink, V., van der Werf, H. W., Stoel, M. G., Schotborgh, C. E., Amoroso, G., Porta, F., van der Kley, F., van Wely, M. H., Gehlmann, H., van Garsse, L. A. F. M., Geuzebroek, G. S. C., Verkroost, M. W. A., Mourisse, J. M., Medendorp, N. M., van Royen, N.

“…Introduction The coronavirus disease 2019 (COVID-19) pandemic has put tremendous pressure on healthcare systems. Most transcatheter aortic valve implantation…”
Get full text

Reclassification of aortic stenosis by fusion of echocardiography and computed tomography in low-gradient aortic stenosis by El Faquir, N., Vollema, M. E., Delgado, V., Ren, B., Spitzer, E., Rasheed, M., Rahhab, Z., Geleijnse, M. L., Budde, R. P. J., de Jaegere, P. P., Bax, J. J., Van Mieghem, N. M.

“…Background The integration of computed tomography (CT)-derived left ventricular outflow tract area into the echocardiography-derived continuity equation…”
Get full text

Patient-specific computer modelling – its role in the planning of transcatheter aortic valve implantation by El Faquir, N., Ren, B., Van Mieghem, N. M., Bosmans, J., de Jaegere, P. P.

“…Transcatheter aortic valve implantation is increasingly used to treat patients with severe aortic stenosis who are at increased risk for surgical aortic valve…”
Get full text

Clinical consequences of consecutive self-expanding transcatheter heart valve iterations by Kroon, H. G., van Gils, L., Ziviello, F., van Wiechen, M. P. H., Ooms, J. F. W., Rahhab, Z., El Faquir, N., Maugenest, A.‑M., Goudzwaard, J. A., Cummins, P., Lenzen, M., Kardys, I., Daemen, J., Mattace-Raso, F., de Jaegere, P. P. T., Van Mieghem, N. M.

“…Objective To compare early clinical outcomes after transcatheter aortic valve implantation (TAVI) with three consecutive generations of self-expanding valves…”
Get full text

Transcatheter mitral valve repair in proportionate and disproportionate functional mitral regurgitation—insights from a small cohort study by Ooms, J. F., Geleijnse, M. L., Spitzer, E., Ren, B., Van Wiechen, M. P., Hokken, T. W., Daemen, J., de Jaegere, P. P. T., Van Mieghem, N. M. D. A.

“…Background Functional mitral regurgitation (FMR) can be subclassified based on its proportionality relative to left ventricular function and end-diastolic…”
Get full text

Changes in demographics, treatment and outcomes in a consecutive cohort who underwent transcatheter aortic valve implantation between 2005 and 2020 by De Ronde-Tillmans, M. J. A. G., Nuis, R. M., Goudzwaard, J. A., Cummins, P. A., Hokken, T. W., Van Wiechen, M. P. H., Ooms, J. F. W., Daemen, J., Van Mieghem, N. M. D. A., Mattace-Raso, F. U. S., Lenzen, M. J., de Jaegere, P. P. T.

“…Introduction Transcatheter aortic valve implantation (TAVI) has matured to the treatment of choice for most patients with aortic stenosis (AS). We sought to…”
Get full text

Redo renal denervation using a multi-electrode radiofrequency system in patients with persistent therapy-resistant hypertension by Daemen, J., Feyz, L., Van Zandvoort, L., Van Mieghem, N. M.

“…Objectives Renal sympathetic denervation has been studied as a potential therapeutic option for patients with therapy-resistant hypertension; however,…”
Get full text

Current MitraClip experience, safety and feasibility in the Netherlands by Rahhab, Z., Kortlandt, F. A., Velu, J. F., Schurer, R. A. J., Delgado, V., Tonino, P., Boven, A. J., Van den Branden, B. J. L., Kraaijeveld, A. O., Voskuil, M., Hoorntje, J., van Wely, M., van Houwelingen, K., Bleeker, G. B., Rensing, B., Kardys, I., Baan jr, J., Van der Heyden, J. A. S., Van Mieghem, N. M.

“…Purpose Data on MitraClip procedural safety and efficacy in the Netherlands are scarce. We aim to provide an overview of the Dutch MitraClip experience…”
Get full text

An update on the use of anticoagulant therapy in ST-segment elevation myocardial infarction by van Gameren, M, Lemmert, M E, Wilschut, J M, Daemen, J, De Jaegere, P P T, Zijlstra, F, Van Mieghem, N M D A, Diletti, R

“…Together with antiplatelet therapy, anticoagulants are vital to improve outcomes in patients presenting with ST-segment elevation myocardial infarction…”
Get more information

Are BVS suitable for ACS patients? Support from a large single center real live registry by Felix, C.M, Onuma, Y, Fam, J.M, Diletti, R, Ishibashi, Y, Karanasos, A, Everaert, B.R.C, van Mieghem, N.M.D.A, Daemen, J, de Jaegere, P.P.T, Zijlstra, F, Regar, E.S, van Geuns, R.J.M

“…Abstract Objectives To investigate one-year outcomes after implantation of a bioresorbable vascular scaffold (BVS) in patients presenting with acute coronary…”
Get full text

Intravascular ultrasound‐guided stenting of left main stem dissection after medtronic corevalve implantation by Mieghem, N.M., Jaegere, P.P.

“…Transcatheter aortic valve implantation (TAVI) implies the introduction, positioning, and deployment of a stented bioprosthesis in the (calcified) native…”
Get full text

The first human experience of a contact force sensing catheter for epicardial ablation of ventricular tachycardia by Dabiri Abkenari, L., Akca, F., Van Mieghem, N. M., Szili-Torok, T.

“…Contact force (CF) is one of the major determinants for sufficient lesion formation. CF-guided procedures are associated with enhanced lesion formation and…”
Get full text

Patients with aortic stenosis referred for TAVI: treatment decision, in-hospital outcome and determinants of survival by Nuis, R. J., Dager, A. E., van der Boon, R. M., Jaimes, M. C., Caicedo, B., Fonseca, J., Van Mieghem, N. M., Benitez, L. M., Umana, J. P., O’Neill, W. W., de Marchena, E., de Jaegere, P. P.

“…Aims To assess treatment decision and outcome in patients referred for transcatheter aortic valve implantation (TAVI) in addition to predictive factors of…”
Get full text

Microsphere embolisation as an alternative for alcohol in percutaneous transluminal septal myocardial ablation by Vriesendorp, P. A., Van Mieghem, N. M., Vletter, W. B., Ten Cate, F. J., de Jong, P. L., Schinkel, A. F. L., Michels, M.

“…Background Percutaneous transluminal septal myocardial ablation using microsphere embolisation is a new interventional technique to treat patients with…”
Get full text

Development Of A Conceptual Model For Early Health Technology Assessment Of Tissue-Engineered Heart Valves by Huygens, SA, Rutten-van Mölken, MP, Bekkers, JA, Bogers, AJ, Bouten, CV, Chamuleau, SA, de Jaegere, PP, Kappetein, AP, Kluin, J, van Mieghem, NM, Versteegh, MI, Witsenburg, M, Takkenberg, JJ

Get full text